dawnpowell

459 POSTS 0 COMMENTS

Creavo wins two awards for its cardiac imaging device

Creavo's Vitalscan
  Creavo Medical Technologies (Creavo) has won two awards at the Institution of Engineering and Technology (IET) Innovation awards (15 November, London, UK) for its...

A bold new study could alter the orbit of elective PCI

The ORBITA (Objective randomised blinded investigation with optimal medical therapy of angioplasty in stable disease) study, recently presented at 2017 Transcatheter Cardiovascular Therapeutics (TCT)...

Nutty eating habits may lower the risk of cardiovascular disease

A study published in the Journal of the American College of Cardiology indicates that people who regularly eat nuts—including peanuts, walnuts and tree nuts...

AHA 2017: First patients enrolled in trial of IASD system for...

Corvia Medical has enrolled the first patients in its global multicentre trial (REDUCE LAP-HF II) of the interatrial shunt device (IASD) for the treatment...

Precommercialisation of Serpentis drug-eluting stent announced

Stentys has announced the precommercialisation of its Serpentis stent. According to a press release, the sirolimus-elutiung stent has a biodegradable coating and is designed...

New study shows significant clinical workflow and staff experience benefits of...

Philips has announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next generation image-guided therapy platform, Azurion. The...

AHA 2017: Fun in the bedroom is unlikely to cause a...

Data published, as a research letter, in the Journal of the American College of Cardiology and presented at the American Heart Association’s Scientific Sessions...

Neovasc receive approval to initiate COSIRA-II IDE clinical trial

Neovasc has received approval of the US FDA to initiate the COSIRA-II IDE clinical trial.  The trial's purpose will be to demonstrate the safety...

TCT 2017: Sham-controlled trial raises doubts about benefit of angiography-guided PCI...

ORBITA (Objective randomised blinded investigation with optimal medical therapy of angioplasty in stable disease)—the first-ever sham controlled trial of percutaneous coronary intervention (PCI)—indicates that...

TCT 2017: Study challenges recommendations on the management of cardiogenic shock

Advice on percutaneous coronary intervention (PCI) strategies for patients with acute myocardial infarction complicated by cardiogenic shock may need to be revised after the...

MitraClip becomes first approved device for transcatheter mitral valve repair in...

Abbott has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved its MitraClip device for treatment of people with mitral regurgitation....

Centers for Medicare and Medicaid Services finalise a new technology ambulatory...

HeartFlow has announced that the Centers for Medicare & Medicaid Services (CMS) has finalised a new technology ambulatory payment classification (APC) for the HeartFlow...

TCT 2017: Elixir reveals new drug-eluting stent

Elixir Medical unveiled for the first time its novel stent technology—Dynamx—at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Denver, USA). A...

TCT 2017: Pooled analysis of Magmaris studies continue to show no...

Data presented during the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Denver, USA), according to a press release, provide further evidence of...

TCT 2017: Next-generation FFR system launched

Acist has announced the global launch of its RXi Mini system—the next-generation system of its RXi Rapid Exchange fractional flow reserve (FFR) system. The...

TCT 2017: 12-month DAPT provides no benefit over six-month DAPT in...

Data from the DAPT-STEMI study, which was presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Denver, USA), indicates that ST-segment...

TCT 2017: Fantom bioresorbable scaffold continues to show positive outcomes at...

The Fantom bioresorbable scaffold (Reva Medical) shows continued positive clinical outcomes according to an interim data set from the FANTOM II clinical trial, which...

TCT 2017: Substantial reduction in mitral regurgitation at 30 days with...

Yesterday data presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting indicated that Medtronic's transcatheter mitral valve implantation device (Intrepid) reduces mitral regurgitation 30...

TCT 2017: No longer any reason to use bare metal stents...

Data from the SENIOR study – presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting – show that percutaneous coronary intervention (PCI) with a...

TCT 2017: TAVI with Sapien 3 or Sapien XT is cost...

Data presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October – 2 November, Denver, USA) suggest that transcatheter aortic valve implantation (TAVI)...

TCT 2017: New data for CoreValve Evolut further support its use...

New clinical research, presented today at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October- 2 November, Denver, USA), support the positive clinical performance...

TCT 2017: Combo dual-therapy stent is non-inferior to Xience at one...

New results from the HARMONEE Japan/US registration trial, which were presented yesterday at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October – 2...

Xience Sierra is now on European market

The CE mark has been awarded to a new-generation of Abbott Vascular's everolimus-eluting, metallic stent Xience. The Xience Sierra, according to a press release,...

TCT 2017: Data for novel cardiac imaging technology unveiled

New data from the ongoing CADLAD (Coronary artery disease learning and algorithm development) study will be presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT)...

TCT 2017: AI-driven cardiac ultrasound company to give two presentations

Bay Labs, a medical technology company developing an artificial intelligence in cardiovascular imaging, has announced that its chief medical officer Randolph P Martin (Emory...

First year after a myocardial infarction poses more risks for women

Woman patient
A team at the Technical University of Munich (TUM) has determined that in the first year after a myocardial infarction, women are subject to...

US FDA 510(k) clearance for its Nova Cross Extreme and Nova...

Nitiloop has received FDA clearance for its new Nova Cross Extreme and Nova Cross BTK. These dedicated microcatheters are joining the Nova Cross product...

Cobra PzF nano-coated stent now being studied with 14-day DAPT in...

The US FDA has approved the expansion of CeloNova’s ongoing clinical trial of its proprietary Cobra PzF nano-coated stent to enable the use of...

Heart valve replacement surgery may not be a morning procedure

David Montaigne (University of Lille, France) and others report in The Lancet that performing heart valve replacement in the afternoon was associated with better...

Controlling blood pressure may help to prevent mitral regurgitation

A new study indicates that long-term exposure to elevated blood pressure is associated with an increased risk of primary and secondary mitral regurgitation. According...

Non beta-blocker therapies are infrequently used in patients experiencing angina after...

Data from the TRANSLATE-ACS (Treatment with adenosine diphosphate receptor inhibitor: longitude assessment of treatment of patterns and events after acute coronary syndrome), published in...

Combing intravascular ultrasound with multispectral fluorescence lifetime imaging may provide comprehensive...

In Scientific Reports, a Nature publication, Julien Bec (Department of Biomedical Engineering, University of California Davis, Davis, USA) and others write that the combination...

TCT 2017: Boston Scientific reveals presentations at conference

Boston Scientific has announced key data will be presented at next week’s Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Denver, USA). For example,...

Claret Medical closes on series C financing of US$14.5m

Claret Medical has announced that it has closed on a series C financing of US$14.5m led by Lightstone Ventures, with participation from existing investors...

First patient implanted with Intrepid TMVI device in APOLLO trial

The first patient in the APOLLO trial has undergone transcatheter mitral valve implantation (TMVI) with the Intrepid device (Medtronic). The study—the first-ever pivotal trial...

Second successful implant of minimally invasive annuloplasty system announced

Micro Interventional has announced that the second successful implantation of its minimally invasive annuloplasty (MIA) technology. The patient was enrolled in the first arm...

Boston Scientific advert

Everolimus-Eluting Platinum Chromium Coronary Stent System Drug-eluting stent technology with a durable polymer has shown encouraging efficacy compared with bare metal stents, significantly reducing restenosis...

Myocardial infarction survivors more likely to use “emotion-focused” strategies to cope...

Data presented at the 8th Emirates Cardiac Society congress (19–21 October, Dubai, UAE), which is held in collaboration with the American College of Cardiology...

“Neurocardiologists” could treat acute ischaemic stroke patients when a neurointerventionalist is...

Thomas Haldis (Sanford Health, Fargo, USA) and others report in EuroIntervention that interventional cardiologists, as “neurocardiologists”, can be trained to perform mechanical thrombectomy safely and...

Fantom bioresorbable scaffold implanted for first time in Switzerland

Reva Medical has announced the commercial expansion of its bioresorbable scaffold Fantom, with the first implantation of the device in Switzerland. The procedure was...

TCT 2017: Elixir Medical to reveal “a game-changing metallic drug-eluting stent...

Elixir Medical has revealed details of its programme and activities during the 2017 meeting of the transcatheter cardiovascular therapeutics (TCT; 29 October–2 November, Denver,...

Cardiology societies come together to provide new assessment options for subspecialities

The American College of Cardiology (ACC), Heart Failure Society of America (HFSA), Heart Rhythm Society (HRS) and Society for Cardiovascular Angiography and Interventions (SCAI)...

Coronary angiography after TAVI with a self-expanding valve is challenging but...

A new study indicates that coronary angiography, with or without percutaneous coronary intervention (PCI), is feasible in patients who have undergone transcatheter aortic valve...

Creavo Medical Technologies receives US FDA 510(k) approval for Vitalscan

The US FDA has granted 510(k) clearance to Creavo Medical Technologies for its portable scanning device, Vitalscan. A press release reports that the move opens...

Relatively few chronic kidney disease patients require dialysis after TAVI

James W Hansen (Lahey Hospital and Medical Center, Burlington, USA) and others report in JACC: Cardiovascular Interventions that the number of patients with chronic...

US doctors urged to take action on gun violence

Garen Wintemute (Violence Prevention Program, University of California Davis, USA), in an editorial in the Annals of Internal Medicine, has called for physicians to...

PCRLV 2017: New ESC guidelines for valvular heart disease represent a...

Bernard Prendergast (Department of Cardiology, St. Thomas' Hospital, London, UK), in this PCR video, outlines the key points of the 2017 European Society of...

First patient enrolled in Frontier IV clinical trial of PerQseal large...

Vivasure Medical has announced the successful enrolment of the first patient in the Frontier IV clinical study, a non-randomised multicentre international trial, designed to...

TCT 2017: Alec Vahanian to receive the Master Clinical Operator award

The Geoffrey O. Hartzler Master Clinical Operator Award will be presented to Alec Vahanian (Cardiology Department, University Paris Diderot, Bichat Hospital, AP-HP, Paris, France)...

Study demonstrates feasibility and safety of RenalGuard of reducing risk of...

A first-in-man, feasibility study of the use of the RenalGuard system in patients undergoing coronary artery bypass grafting (CABG) shows the potential of RenalGuard...

CADScor system shown at the German Heart Days meeting

Acarix AB has presented its CADScor system for non-invasive, non-radiation acoustic rule-out of coronary artery disease at the German Heart Days meeting (12–14 October,...

Pamela B Morris to be next American College of Cardiology scientific...

Pamela B Morris has been selected as the next vice chair of the American College of Cardiology (ACC) annual scientific session. She will serve...

Enrolment in BIOVITESSE trial of polymer-free coronary stent initiated

Biotronik has announced the start of enrolment in a coronary stent trial aiming at assessing the safety and clinical performance of a new coronary...

Data for NobleStitch EL suture based closure system presented at CSI...

At CSI UCSF Congress, Achille Gaspardone (Hospital of Sant'Eugenio, Rome, Italy) presented a comprehensive report on closure of patent foramen ovale (PFO) and related atrial...

Thomas F Lüscher becomes director of education, research and development at...

Thomas Lüscher has been appointed director of education, research and development at Royal Brompton & Harefield NHS Foundation Trust.  A press release reports that...

EACTS 2017: Vascular Graft Solutions to hold symposium on venous external...

Vascular Graft Solutions is hosting a symposium on the future of coronary artery bypass grafting (CABG) at the European Association for Cardio-Thoracic Surgery (EACTS)...

No significant differences in post TAVI outcomes between African Americans and...

Fahad Alqahtani (Division of Cardiology, West Virginia University Heart & Vascular Institute, Morgantown, USA) and others report in Catheterization and Cardiovascular Interventions that there...

First patient enrolled in US arm of ALIVE pivotal clinical trial

BioVentrix has announced that the first patient has been enrolled in the US arm of the ALIVE pivotal clinical trial. The trial is designed...

Essential Medical completes enrolment in US IDE trial of Manta

Essential Medical has announced the completion of enrolment in the US pivotal investigational device exemption (IDE) trial of the Manta large bore vascular closure...

First procedure performed in Rox Medical’s CONTROL HTN-2 clinical trial

The first patient was treated in the CONTROL hypertension (HTN)-2 clinical study, the Rox Medical’s pivotal study to evaluate the safety and effectiveness of...

Missing out on breakfast may increase risk of atherosclerosis

A study published in the Journal of the American College of Cardiology indicates that people who do not eat breakfast have an increased risk...

Sirolimus-coated balloon “may represent a new approach to treating in-stent restenosis”

Stefan Verheye (Antwerp Cardiovascular Centere ZNA Middelheim, Interventional Cardiology, Antwerp, Belgium) and others report in JACC: Cardiovascular Interventions that the use of a sirolimus-coated...

Enrolment completed in US pivotal clinical study of Cardioform ASD Occluder

Gore has completed enrolment for the pivotal phase of its Gore ASSURED Clinical Study. This investigational device exemption (IDE) trial is researching the company’s...

PCR LV 2017: Refining implantation technique and device iterations may improve...

New data from REPRISE III indicate that keeping the bottom of the frame at annular level while implanting and targeting a final depth of...

Bioresorbable valves: Insights into a potential game-changing technology

The burden of cardiovascular mortality and morbidity is constantly increasing in Western countries and, at the same time, acquired and congenital valvular diseases are...

From SYMPLICITY HTN-1 to SPYRAL HTN-OFF MED: The story of renal...

It is now almost a decade since the first patient underwent catheter-based renal denervation as a participant in a safety and proof-of concept study...

Philippe Généreux appointed chief medical officer of Saranas

Saranas has announced the appointment of Philippe Généreux as its chief medical officer. Généreux is the co-director of the Structural Heart Disease Program at...

Optiflow arterial cannulae family launched onto the USA

LivaNova has received FDA 510(k) clearance for the US market launch of its Optiflow arterial cannulae family.  A press release reports that the Optiflow...

iVascular’s drug-eluting stent and drug-eluting balloon now available for sale in...

iVascular SLU has received approval for selling its coronary and peripheral products in India. Therefore, the company’s coronary drug-eluting stent, coronary dug-coated balloon, as well...

American College of Cardiology says that reforms to US healthcare come...

The president of the American College of Cardiology (ACC), Mary Norine Walsh, has said that “it is concerning” that the Graham-Cassidy proposal (for US...

FORWARD PRO clinical study to evaluate longer term performance of CoreValve...

A new post-market clinical study is to evaluate Medtronic’s CoreValve Evolut Pro transcatheter aortic valve implantation (TAVI) valve in everyday clinical practice. Studying patients...

FDA grants Abiomed pre-market approval for is Impella RP for right...

Abiomed has received FDA pre-market approval for its Impella RP heart pump. Culminating from five years of research, according to a press release, this...

Direct stenting with drug-eluting stents may be associated with better outcomes

Marco A Magalhaes (Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC, USA) and others report in Catheterization and Cardiovascular Interventions that direct...

Three studies support efficacy of PFO closure for reducing risk of...

The results of CLOSE, Gore Reduce and the extended follow-up of RESPECT—all published in The New England Journal of Medicine—indicate that percutaneous closure of...

Cancer history influences treatment of myocardial infarction

Dragana Radovanovic (AMIS Plus Data Centre, Zurich, Switzerland) and colleagues report in the European Heart Journal: Acute Cardiovascular Care that the treatment of myocardial infarction...

PCR LV 2017: The optimal modalities for imaging for mitral and...

As the field of structural heart interventions expands from the now-established transcatheter therapies for native aortic stenosis to include treatment of mitral and tricuspid...

CardiAMP Heart Failure trial to further evaluate use of regenerative therapy...

BioCardia has revealed the trial design for its pivotal Phase III CardiAMP Heart Failure Trial at the Texas Heart Institute International Symposium on Cardiovascular...

Carag completes CE marking for its breakthrough Carag bioresorbable septal occluder

Carag has announced that it has completed CE marking for its Carag bioresorbable septal occluder. A press release reports that the device is a...

FDA grants 510(k) clearance to Fysicon’s QMAPP haemodynamic monitoring system

Fysicon has announced that it has received 510(k) FDA clearance for its QMAPP haemodynamic monitoring system. A press release reports that QMAPP offers cardiologists...

All-comers data indicate stroke-free survival is improved with Sentinel embolic protection...

Jochen Wöhrle (Department of Internal Medicine II, Cardiology, University of Ulm, Ulm, Germany) and his team report in JACC: Cardiovascular Interventions that, in an...

Caucasians have a higher incidence of an out-of-hospital cardiac arrest but...

There is a lack of sufficient data about the effect of racial differences on outcomes following an out-of-hospital cardiac arrest. Therefore, Karuppiah Arunachalam and...

New meta-analysis finds RenalGuard reduces all-cause mortality in patients undergoing cardiac...

Anand Prasad (Department of Medicine, Division of Cardiology, University of Texas Health Science Center, San Antonio, USA) and others report in the Journal of...

Edwards Lifesciences’ Alterra adaptive prestent device used for first time to...

Evan Zahn (Guerin Family Congenital Heart Program, Cedars-Sinai Heart Institute, Los Angeles, USA) has become the first interventional cardiologist to implant the Alterra adaptive...

ESC 2017: Further decreasing mortality after STEMI will be difficult

According to results from the FAST-MI programme, six-month mortality after ST-segment elevation myocardial infarction (STEMI) and after non-STEMI (NSTEMI) considerably decreased between 1995 and...

ADVERT: Edwards SAPIEN 3 Transcatheter Heart Valve

JTNDbWV0YSUyMGh0dHAtZXF1aXYlM0QlMjJyZWZyZXNoJTIyJTIwY29udGVudCUzRCUyMjAlM0IlMjBVUkwlM0QlMjdodHRwJTNBJTJGJTJGd3d3LmVkd2FyZHMuY29tJTJGZ2IlMkZkZXZpY2VzJTJGSGVhcnQtVmFsdmVzJTJGVHJhbnNjYXRoZXRlci1TYXBpZW4tMyUzRnV0bV9zb3VyY2UlM0RjYXJkaW92YXNjdWxhci1uZXdzJTI2dXRtX21lZGl1bSUzRGRpc3BsYXklMjZ1dG1fY2FtcGFpZ24lM0RFZHdhcmRzX0VVXzIwMTclMjZ1dG1fY29udGVudCUzRGNhcmRpb3Zhc2N1bGFyLW5ld3NfUzNfTGlmZV9Jc19XYWl0aW5nXzYwMHg0MDAlMjclMjIlMjAlMkYlM0U= Patients. Our mission for life. Together, we can do even more than help patients. Join Edwards Lifesciences on our mission to change lives.

TCT 2017: Cardiovascular Research Foundation announces late-breaking trials and first-report investigations

The Cardiovascular Research Foundation (CRF) has release details of the 12 late-breaking trials and 16 first report investigations that are to be presented at...

Neovasc provides Tiara clinical update

Neovasc has provided an update on the study progress and clinical performance of the Tiara valve, a self-expanding mitral bioprosthesis for transcatheter implantation in...

First patient enrolled in PRECISION GRX registry

Corindus Vascular Robotics has announced that the first patient has been enrolled in its PRECISION GRX registry, which is a post-market study of its...

New literature review highlights that Perceval sutureless aortic valve is safe

Corey Adams (Health Science Center, St John’s, Canada) and others report in the latest issue of Innovations that the Perceval sutureless aortic valve (LivaNova)...

Court of Dusseldorf grants Alvimedica an injunction against A B Handels...

Alvimedica has announced that the Court of Dusseldorf (Germany) has recognised in full the CID-Alvimedica rights on intellectual properties regarding the principles and related...

ESC 2017: Post-TAVI clinical leaflet thrombosis is “infrequently reported” but is...

Of 5,691 adverse events following transcatheter aortic valve implantation (TAVI) that were reported to the FDA’s manufacturer and user facility device experience (MAUDE) database,...

ESC 2017: More evidence that supplemental oxygen in normoxic patients with...

Data from DET02X-AMI (Determination of the role of oxygen in suspected acute myocardial infarction) show that supplemental oxygen in normoxic patients with suspected myocardial...

“Low commercial sales” prompt Abbott to pull the plug on selling...

Abbott has announced that it is to stop selling its first-generation bioresorbable vascular scaffold (Absorb, Abbott Vascular) because of poor sales. The announcement follows...

Minimally invasive annuloplasty has been used to successfully perform bicuspidisation of...

Micro Interventional Devices has announced that its minimally invasive annuloplasty (MIA) technology has been successfully used for the first time to perform a tricuspid valve bicuspidisation...

ESC 2017: Alternative strategies needed for treating stenotic lesions in saphenous...

The recent DIVA (Drug-eluting stents vs. bare metal stents in saphenous vein graft angioplasty) trial, which was presented at the European Society of Cardiology...

ESC 2017: CABG is the “preferred strategy” for multivessel revascularisation in...

Data from a nationwide observational cohort study indicate that coronary artery bypass grafting (CABG) should be used instead of percutaneous coronary intervention (PCI) to...

Good care means ensuring patients are thoroughly informed

In 2010, Harlan M Krumholz wrote a commentary in the Journal of the American Medical Association (JAMA) about the need for true informed consent...

ProtEmbo cerebral protection system used for first time

The ProtEmbo cerebral protection system (Protembis) has been used, to complement a transcatheter aortic valve implantation (TAVI) procedure, for the first time in a...

American societies come together to publish appropriate use criteria for valvular...

The American College of Cardiology and several partnering societies—including the American Heart Association (AHA) and Society for Cardiovascular Angiography and Interventions (SCAI)—have released a...

Cardiovascular News Issue 46 – September 2017 US edition

To mark angioplasty’s ruby anniversary, in this issue (47; September 2017), we bring you a case report on the first-ever PCI & and review how technology...

Cardiovascular News Issue 46 – September 2017

To mark angioplasty's ruby anniversary, in this issue (47; September 2017), we bring you a case report on the first-ever PCI & and review how technology...

C Michael Gibson

C Michael Gibson (Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical, Harvard Medical School, Boston, USA) receives “instant gratification” from making a patient...

The ATI score: A new tool to triage novel treatments in...

Mechanical reperfusion via primary percutaneous coronary intervention (PCI) in combination with optimised antithrombotic therapy and antiplatelet therapy is the current gold-standard treatment for ST-segment...

The need to determine the relevance of stent malapposition

Despite a constant evolution in stent/scaffold design, stent failure is still perceived as a clinical problem. The process of drug-eluting stent struts thinning that...

Ruby anniversary: 1977 – A remarkable year for kings and queens

History was made on 16 September 1977 when Andreas Grüntzig performed world’s first in-human coronary angioplasty procedure—paving the way for percutaneous coronary intervention (PCI)...

ESC 2017: Young cardiologists discuss highlights of congress

In this video from the European Society of Cardiology (ESC), Steen Dalby Kristensen (Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark) talks to members...

Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval

The FDA has approved the Full MagLev HeartMate 3 (Abbott) left ventricular assist device for use in heart failure patients in need of short-term...

ESC 2017: MobiusHD implant shown to reduce resistant hypertension

The European results of the first-in-human trial of Vascular Dynamics’ MobiusHD implant indicate that the device is associated with a reduction in 24-hour ambulatory...

A 52mm tricuspid valve successfully implanted into a transplanted heart

The Gate catheter-guided tricuspid atrioventricular valved stent (NaviGate Cardiac Structures) has been successfully implanted through the jugular vein into a transplanted heart that was...

ESC 2017: Rivaroxaban significantly lowers risk of stroke, cardiovascular death, and...

The COMPASS study, which was presented at the European Society of Cardiology (ESC) congress (26–30 August, Barcelona, Spain), has shown that rivaroxaban (Xarelto, Bayer)...

Global agreement between Philips and HeartFlow announced

Philips and HeartFlow have announced that they have entered into a collaboration agreement with the goal of improving access to diagnostic and planning tools...

ESC 2017: Subanalysis of PEGASUS shows ticagrelor reduces cardiovascular death by...

A new subanalysis from the phase III PEGASUS-TIMI 54 trial, which was presented at the European Society of Cardiology (ESC) congress (26–30 August, Barcelona,...

US trial to evaluate safety and efficacy of Amplatzer for patent...

Abbott has initiated a US pivotal clinical study evaluating the safety and effectiveness of a modified version of its Amplatzer device to correct patent...

Several barriers need to be overcome to make “telestenting” feasible

A robotic system for performing percutaneous coronary intervention (PCI) is now clinically available and is being used routinely to perform PCI at multiple centres...

ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for...

During a late-breaking science session at the European Society of Cardiology (ESC) congress (26–30 August, Barcelona, Spain), Pim Tonino (Heart center Catharina Hospital, Eindhoven,...

ESC 2017: Best-practice PCI outperforms conventional PCI in patients with de...

The SYNTAX II study has found that percutaneous coronary intervention (PCI) using state-of-the-art techniques—including physiological assessment and a new-generation drug-eluting stent—significantly reduces the rate...

ESC 2017: SPYRAL HTN-OFF MED provides “proof of principle” that renal...

Results from SPYRAL HTN-OFF MED indicate that renal denervation, compared with a sham procedure, significantly reduces blood pressure in patients with hypertension who are...

ESC 2017: Significantly lower event rates with Orsiro than with Xience

  Results from the BIOFLOW V study indicate that patients who undergo percutaneous coronary intervention (PCI) using a sirolimus-eluting stent with a biodegradable polymer (Orsiro,...

ESC 2017: Case builds for dropping aspirin from triple therapy in...

The RE-DUAL PCI trial indicates that dual therapy with the non-vitamin K antagonist oral anticoagulant dabigatran (Pradaxa, Boehringer Ingelheim)—and not aspirin—and a P2Y12 inhibitor...

ADVERT: Patients have to trust that if I were in their...

PG1ldGEgaHR0cC1lcXVpdj0icmVmcmVzaCIgY29udGVudD0iMDsgVVJMPSdodHRwOi8vd3d3LmJvc3RvbnNjaWVudGlmaWMuY29tL2VuLVVTL3Byb2R1Y3RzL3N0ZW50cy0tY29yb25hcnkvYmlvYWJzb3JiYWJsZS1zdGVudC1zeXN0ZW0uaHRtbD9jaWQ9ZHNwMTc2Njg4JyIgLz4=SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System Drug Eluting stent technology with durable polymer has shown encouraging efficacy compared to bare metal stents, significantly reducing restenosis...

Novel mitral regurgitation therapy featured in Innovation Summit at Cardiovascular Innovations

4C Medical Technologies has announced that its medical device therapy for mitral regurgitation was featured in the Innovation Summit at Cardiovascular Innovations (CVI) 2017...

Medtronic’s Avalus pericardial valve receives CE mark and FDA approval

Medtronic has announced CE mark and FDA approval of its new Avalus pericardial aortic surgical valve for the treatment of aortic valve disease.  According...

SHS invests in heart valve-repair start-up CoreMedic

SHS Gesellschaft für Beteiligungsmanagement is investing in CoreMedic, a start-up developing transfemoral repair systems to treat heart valve malfunctions. SHS is investing from its...

Pneumonia or sepsis increases risk of cardiovascular disease in first year...

Scott Montgomery (Örebro University, Örebro, Sweden) and colleagues report in the European Journal of Preventive Cardiology that pneumonia or sepsis in adults that results...

Absorb prompts Boston Scientific to rethink its bioresorbable scaffold programme

According to the US newspaper Star Tribune, Boston Scientific is to stop investing in its bioresorbable scaffold trial programme. The paper reports that the...

Keystone Heart accelerate trials for third-generation of its TriGuard device

Keystone Heart has announced plans to initiate clinical trials for a new, advanced version of its TriGuard cerebral embolic protection device. A press release...

CE mark for CoreValve Evolut Pro

Medtronic has received the CE mark for its CoreValve Evolut Pro valve for the treatment of severe aortic stenosis for symptomatic patients who are...

Merit Medical partners with world-renown interventional cardiologist to deliver transradial course

Merit Medical will partner with internationally renowned interventional cardiologist Ferdinand Kiemeneij to deliver the next generation in educational opportunities for interventional cardiologists and interventional...

Ruby anniversary: The key revolutions of the past 40 years

Advances in materials and techniques over the past 40 years have led to a substantial reduction in major adverse cardiovascular events. Giuliana Capretti and...

New study to evaluate safety of three-month DAPT with Xience in...

A new study, XIENCE Short DAPT, will evaluate whether three months of dual antiplatelet therapy (DAPT) is non-inferior to the standard duration of DAPT...

American College of Cardiology says it opposes US healthcare reform

The American College of Cardiology (ACC) president Mary Norine Walsh has issued a statement on upcoming Senate vote to precede to US healthcare reform...

Roxwood Medical announces agreement with Abbott for distribution of products in...

Roxwood Medical has entered into an exclusive agreement with Abbott for distribution of Roxwood products in the USA. According to a press release, the...

Black people do not have a higher rate of mortality one...

Taisei Kobayashi (Corporal Michael J Crescenz, Veterans Affairs Medical Center, Philadelphia, USA) and others report in JAMA Cardiology that—after adjustment for demographics, comorbidities and...

Orodispersible tablets of ticagrelor now available in the UK

AstraZeneca has announced the UK availability of ticagrelor (Brilique) 90mg orodispersible tablets. This follows the European Commission’s marketing authorisation of the formulation in May...

Health Canada approves a high-dose bolus regimen of tirofiban

Cardiome Pharma has announced that the Therapeutic Products Directorate of Health Canada has approved the tirofiban (Aggrastat) 25mcg/kg high-dose bolus regimen, as requested under...

Philips adds to list of recent acquisitions by buying TomTec

Philips has signed an agreement to acquire TomTec Imaging Systems GmbH, a provider of intelligent image analysis software, especially for diagnostic ultrasound. Headquartered in...

Study finds that initiatives to improve medication adherence after myocardial infarction...

Kevin G Volpp (Center for Health Incentives & Behavioral Economics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA) and others report in JAMA...

EuroPCR 2017: A “golden era” for valve disease therapies

At this year’s EuroPCR (16–19 May, Paris, France), Philip MacCarthy writes, I had the pleasure of welcoming onto the podium a team of determined cyclists...

Embolic protection device company raises US$5million in series B financing for...

Innovative Cardiovascular Solutions has announced today completion of an oversubscribed Series B round of financing totalling US$5M. The company is currently developing the Emblok...

First myocardial infarction more likely to be fatal in black people

Monika Safford (John J Kuiper Professor of Medicine and Chief of General Internal Medicine at Weill Cornell Medical College, New York, USA) and others...

CoreValve Evolut can be used to treat intermediate-risk patients in the...

Medtronic has announced that the FDA has approved the company’s self-expanding transcatheter aortic valve implantation (TAVI) system CoreValve Evolut for the management of intermediate-risk...

Essential Frailty Toolset may be best assessment of frailty for aortic...

Jonathan Afilalo (Division of Cardiology, Jewish General Hospital, McGill University, Montreal, Canada) and others report in the Journal of American College of Cardiology that...

FDA approve “first-in-class” resilient surgical valve

Edwards Lifesciences has FDA approval for its Inspiris Resilia surgical aortic valve, which a press release reports is the first in a new class...

NHS hospital failed to comply with UK law when it gave...

The UK’s Information Commissioner’s Office (ICO) has found that the Royal Free NHS Foundation Trust (London, UK) did not adhere to the UK’s Data...

CSI 2017: Global postmarket surveillance study to explore use of LAmbre...

LifeTech, at the 2017 Congenital and Structural Intervention Congress (CSI; 28 June—1 July, Frankfurt, Germany), announced the launch of a three-year global postmarket surveillance...

Further data to support use of new-generation drug-eluting stents in women

A new study from the Women in Innovation Initiative and Drug-Eluting Stents (WIN-DES) collaborative has found that the use of new-generation drug-eluting stents is...

Nearly one in 10 US TAVI procedures is off label but...

Ravi S Hira (Section of Cardiology, University of Washington, Seattle, USA) and others report in JAMA Cardiology that 9.5% of US transcatheter aortic valve...

Simple but effective animation shows difference between a MI and a...

The British Heart Foundation has produced a video to help the general public understand the difference between a myocardial infarction and a cardiac arrest. The...

New hybrid operating room at Getinge Experience Center in Germany

Getinge has announced the opening of a new modern hybrid operating room (OR) at its Experience Center in Rastatt, Germany. The Hybrid OR, a...

Haemodynamic support with Impella 2.5 heart pump significantly improves survival when...

  A study published in the Journal of Interventional Cardiology indicates that the use of the Impella 2.5 heart pump (Abiomed) is associated with a...

First European patient enrolled in study of percutaneous tricuspid repair system

Mitralign has announced the start of its SCOUT II study in Europe; the study is evaluating the company’s Trialign percutaneous system for the treatment...

Philips to acquire Spectranetics “to accelerate expansion” in its image-guided therapy...

Philips and Spectranetics have announced that they have entered into a definitive merger agreement. Pursuant to the agreement, a press release reports, Philips will...

EuroPCR 2017: Study provides “first step” towards showing long-term durability of...

New data presented, by Luca Testa (Department of Cardiology, IRCCS Policlinico S. Donato, Milan, Italy), at EuroPCR (16–19 May, Paris, France) indicates that there...

Patients benefit from participating in clinical trials

With our population rapidly ageing and improvements in care in other conditions—enabling people to live longer—cardiovascular disease remains the leading cause of death worldwide....

EuroPCR 2017: No risk factor identified for early stroke events in...

  A review of the neurological complications that occurred after surgical aortic valve replacement or transcatheter aortic valve implantation (TAVI) in the SURTAVI (Surgical replacement and...

Study confirms that volume matters for achieving lower in-hospital mortality after...

A study, published in EuroIntervention, provides further evidence that there is an inverse relationship between the number of transcatheter aortic valve implantation (TAVI) procedures...

EuroPCR 2017: Switching to clopidogrel after one month reduces bleeding without...

Data from the TOPIC (Timing of platelet inhibition after acute coronary syndrome) study indicate that swapping a new potent P2Y212 blocker for the less...

Bicuspid aortic stenosis: TAVI’s next challenge

Most of the initial registries, and the large randomised trials, for transcatheter aortic valve implantation (TAVI) excluded patients with bicuspid aortic valves. The presence...

Improving processes and outcome performance measures may be more be relevant...

Alexander C Fanaroff (Division of Cardiology, Duke University, Durham, USA) and others report in the Journal of the American College of Cardiology that nearly...

EuroPCR 2017: Greater risks with standard approach of dual antiplatelet therapy...

The ARTE study, which was simultaneously presented at EuroPCR (16–19 May, Paris, France) and published in JACC: Cardiovascular Interventions, indicates that dual antiplatelet therapy...

TVT 2017: Presentation showcases safety of Tempo temporary pacing lead

BioTrace Medical announced that its Tempo temporary pacing lead was featured in an oral presentation during the 2017 Transcatheter Valve Therapies (TVT) meeting (14–17...

Non-invasive approach could be used to improve valve opening functioning of...

Emmanuel Messas (Hôpital Européen Georges Pompidou, Paris, France) and colleagues report in JACC: Basic to Translational Science that pulsed cavitation ultrasound can be used...

Venus Medtech buys InterValve

Venus Medtech has purchased InterValve, which sells balloon aortic valvuloplasty products and is focused on transcatheter aortic valve treatment. A press release reports that...

US centres of TAVI excellence start to use newly approved Sentinel...

Claret Medical has announced that several of the largest centres of excellence for transcatheter aortic valve implantation (TAVI) have now performed the first US...

ESC calls for sex-specific drug dosages of cardiovascular medication

Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper from the European Society of Cardiology (ESC)....

Risk of bleeding with aspirin in patients older than 75 is...

Peter Rothwell (University of Oxford, Oxford, UK) and colleagues report in The Lancet that long-term use of aspirin in people aged 75 or older...

EuroPCR 2017: Safety of deferring stenting in acute coronary syndrome patients...

A pooled patient-level analysis of patients undergoing physiological assessment, with either fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR), indicates that deferring coronary...

EuroPCR 2017: PCI outperforms medical management for treatment of chronic total...

According to a study presented at EuroPCR (16–19 May, Paris, France), compared with optimal medical therapy alone, percutaneous coronary intervention (PCI) significantly improves the...

Survival benefit of early intervention in non-STEMI patients is independent of...

Sameer Arora (Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, USA) and others report in Catheterizations and Cardiovascular Interventions that...

Dose-tracking system reduces radiation exposure to patients during PCI

A new study suggests that a novel skin dose-tracking system (Toshiba) may reduce radiation exposure in patients undergoing percutaneous coronary intervention (PCI). However, the...

HLT’s TAVI system implanted in first US patients

The first patients in an early feasibility study of HLT’s transcatheter aortic valve implantation (TAVI) system have been implanted with the device. The implant...

OrbusNeich announces FDA clearance and launch of coronary dilatation catheters

OrbusNeich has announced the launch of its Sapphire percutaneous coronary angiography balloon dilatation catheters (Sapphire II PRO and Sapphire NC Plus) following their recent...

Ruby anniversary: Peculiarities about the world’s first PCI

On 16 September 1977, Bernhard Meier helped Andreas Grüntzig to perform the world’s first in-human coronary angioplasty procedure. In this commentary, he reviews the...

TVT 2017: “I predict a very exciting and bright future” for...

This year marks the 10th anniversary of the Transcatheter Valve Therapies (TVT) meeting (14–17 June, Chicago, USA). Course director Martin B Leon (Interventional Vascular...

Sentinel becomes first cerebral protection device to receive FDA approval

Claret Medical has received regulatory clearance from the FDA for its Sentinel cerebral protection system, via de novo classification, meaning that the device can...

EuroPCR 2017: Interventional management of acute heart failure—which device, when and...

In this PCR video, filmed during EuroPCR (16–19 May, Paris, France), Atul Pathak (Clinique Pasteur, Toulouse, France) speaks to Daniel Burkhoff (Division of Cardiology, Columbia...

Award-wining system could be used to inform future surgeons about procedural...

David Wald (Barts Heart Centre, St Bartholomew’s Hospital, London, UK) and his 16-year-old son Ben have designed a system that will enable surgeons, via...

EuroPCR 2017: Study finds no association between implantation technique and risk...

A study—AIDA (Amsterdam investigator-initiated Absorb strategy all-comers trial)—presented at EuroPCR  (16–19 May, Paris, France) and published in The New England Journal of Medicine has...

Vinayak Bapat

Vinayak—“Vinnie”—Bapat (New York Presbyterian Hospital/Columbia Medical Center, New York, USA) was all set to become a fighter pilot in the Indian air force until...

Cardiovascular News Issue 45 – May 2017 US edition

The top story this issue (45; May 2017) reviews whether iFR, following the results of DEFINE-FLAIR and SWEDEHEART, is set to become the new...

Cardiovascular News Issue 45 – May 2017

The top story this issue (45; May 2017) reviews whether iFR, following the results of DEFINE-FLAIR and SWEDEHEART, is set to become the new...

EuroPCR 2017: Head-to-head study validates consistent performance of FFR microcatheter

ACIST Medical Systems announced results from the ACIST-FFR study (Assessment of catheter-based interrogation and standard techniques for fractional flow reserve measurement), which demonstrated—a press...

EuroPCR 2017: No stent thrombosis with Resolute Onyx drug-eluting stent 2mm

Data for  the Resolute Onyx drug-eluting 2mm stent (Medtronic), which were presented at EuroPCR (16–19 May, Paris, France), indicate that device is not associated...

EuroPCR 2017: Excellent early outcomes for Edwards Lifesciences’ self-expanding valve

According to late-breaking trial presented at EuroPCR (16–19 May, Paris, France), a novel self-expanding transcatheter aortic valve implantation device (TAVI, Centera, Edward Lifesciences) is...

EuroPCR 2017: Low risk of scaffold thrombosis with Magmaris

Data presented at EuroPCR (16–19 May, Paris, France) indicate that a metallic bioresorbable scaffold (Biotronik) is associated with a lower risk of scaffold thrombosis...

Positive results for Gore’s PFO closure device

Gore has announced positive results from the REDUCE study, which is assessing the safety and efficacy of its septal occluder devices for the percutaneous...

EuroPCR 2017: Lotus TAVI device has superior efficacy to CoreValve at...

Data from the REPRISE III trial indicate that the Lotus transcatheter aortic valve implantation (TAVI) device (Boston Scientific) is associated with a significantly lower...

EuroPCR 2017: Teleflex introduce new Arrow AC3 Optimus intra-aortic balloon pump

Teleflex showcased its complex percutaneous coronary intervention (PCI) product portfolio, recently acquired from the purchase of Vascular Solutions, and the new Arrow AC3 Optimus...

No difference in rate of adverse cardiovascular events when comparing anticoagulants

In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), according to a study published in JACC: Cardiovascular Interventions,...

EuroPCR 2017: ABSORB China and ABSORB show both comparable safety and...

Data presented from ABSORB China and ABSORB Japan at EuroPCR (16–19 May, Paris, France) show the bioresorbable scaffold Absorb (Abbott Vascular) to have comparable...

SCAI 2017: New data from PLATINUM Diversity study provide further insight...

New analyses from the PLATINUM Diversity study underscore the need for greater understanding of the clinical and nonclinical barriers that can adversely affect stent-related...

Boston Scientific closes Symetis acquisition

Boston Scientific Corporation has announced the close of its acquisition of Symetis SA, a privately-held Swiss structural heart company focused on transcatheter aortic valve...

NaviGate Cardiac Structures reports first heterotopic transcatheter Gate tricuspid valved stent...

NaviGate Cardiac Structures has announced that the Gate catheter-guided tricuspid atrioventricular valved stent was implanted through the jugular vein one week ago in a...

The need to determine the relevance of stent malapposition

Despite a constant evolution in stent/scaffold design, stent failure is still perceived as a clinical problem. The process of drug-eluting stent struts thinning that...

The role of nurses in ensuring a patient-focused TAVI service

Preadmission clinics for patients awaiting elective procedures or surgery are not a new concept. Over the years, several studies have highlighted the multiple benefits...

Reduced baseline left ventricular function may explain female survival benefit after...

A new study indicates that the apparent survival benefit after transcatheter aortic valve implantation (TAVI) that women have over men relates to the baseline...

GE Healthcare receives FDA indication approval for Visipaque injection for use...

GE Healthcare announced that it has received an indication approval from the FDA for its imaging agent Visipaque (iodixanol) Injection. Visipaque 320mg Iodine/mL is...

LivaNova acquires Caisson Interventional

LivaNova has announced it has acquired the remaining outstanding interests in Caisson Interventional in support of its strategic growth initiatives. Based in Maple Grove...

Risk-adjusted 30-day readmission rates are not associated with in-hospital quality of...

Ambarish Pandey (Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, USA) and others report in JAMA Cardiology that risk-adjusted 30-day readmission rates...

Daiichi Sankyo initiates ENVISAGE-TAVI AF study to investigate once-daily edoxaban in...

The ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on clinical outcomes exclusively in atrial fibrillation patients...

Teleflex receives FDA 510(k) Clearance for its Arrow AC3 Optimus intra-aortic...

Teleflex has announced 510(k) clearance from the FDA for its AC3 Optimus intra-aortic balloon pump (IABP). A press release reports that device helps a...

Patient enrolled in STEMI DTU feasibility study

Abiomed announced today the enrolment of the first patient in the FDA approved prospective feasibility study, STEMI Door to Unloading (DTU) with Impella CP...

Multicentre study demonstrates 3D Echo image analysis with Philips’ HeartModelA.I. is...

Philips has announced the results from a global study indicating that automated three-dimensional echocardiographic (3DE) analysis of left-heart chambers is an accurate alternative to...

New data reaffirms value of Perceval for aortic valve replacement in...

LivaNova has announced the presentation of data from multiple studies demonstrating the safety and the effectiveness of the Perceval sutureless valve for aortic valve...

Meta-analysis supports transaortic approach in TAVI

A meta-analysis of single-centre studies indicates that the use of the transaortic appraoch in patients undergoing transcatheter aortic valve implantation (TAVI) is associated with...

High HbA1c levels after coronary intervention may predict risk of adverse...

A new study indicates that patients with glycosylated haemoglobin A (HbA1c) ≥7 at two years after undergoing percutaneous coronary intervention (PCI) have a higher...

Absorb GTS to be restricted to registry use only in Europe

Abbott Vascular has written a letter to European physicians to say that from 31 May, its bioresorbable vascular scaffold (Absorb) will only be available...

TAVI pacemaker issue is “an engineering problem that will be solved”

The SURTAVI trial indicates that transcatheter aortic valve implantation (TAVI)  with CoreValve/CoreValve Evolut R (Medtronic) is non-inferior to surgery for the management of severe...

Fantom II trial to include more complex cases

REVA Medical has announced that it has been granted approval to conduct an expanded clinical trial for its Fantom bioresorbable scaffold in Germany. The...

ACC 2017: Dual anti-thrombotic approach has similar risk of bleeding to...

The GEMINI-ACS study, which was simultaneously presented at the 2017 scientific sessions of the American College of Cardiology (ACC; 17–19 March, Washington, DC, USA)...

ACC 2017: Viagra may reduce cardiovascular outcomes after a first myocardial...

Daniel P Andersson (Department of Medicine, Karolinska Institutet, Unit of Endocrinology, Metabolism, and Diabetes, Karolinska University Hospital, Stockholm, Sweden) and others report in Heart...

The use of bioresorbable scaffold in clinical practice

At JIM 2017 (9-11 February, Milan, Italy), we spoke to Bernardo Cortese (Interventional Cardiology, A.O. Fatebenefratelli, Milano, Italy) about how he uses bioresorbable scaffolds...

Atherectomy is an important tool for optimising results of PCI in...

Evan Shlofmitz (Northwell Health, Manhasset, USA) presented the results of the COAP-PCI (Clinical outcomes of atherectomy prior to percutaneous coronary intervention) study at Cardiovascular...

ACC 2017: FDA approves launch of CoreValve Evolut Pro

The FDA has approved Medtronic’s CoreValve Evolut Pro transcatheter aortic valve implantation (TAVI) device. This approval follows data for the device that were presented...

ACC 2017: “iFR may be the new standard” of physiological assessment...

Writing in The New England Journal of Medicine, Deepak L Bhatt (Brigham and Women’s Hospital and Vascular Center and Harvard Medical School, Boston, USA)...

ACC 2017: PCSK9 inhibitor evolocumab significantly reduces the risk of cardiovascular...

Data for a new drug that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) show that it is associated with a near 60% reduction in...

ACC 2017: Two-year rate of target lesion failure significantly higher with...

Two-year data from the ABSORB III study indicate that a bioresorbable vascular scaffold (Absorb, Abbott Vascular) is associated with a significantly higher rate of...

ACC 2017: No significant differences in two-year morality between bicuspid and...

Sung-Han Yoon (Cedars-Sinai Heart Institute, Los Angeles, USA) and others report in the Journal of the American College of Cardiology that all-cause mortality at...

ACC 2017: CoreValve non-inferior to surgery in intermediate-risk patients

Results from the SURTAVI clinical trial, which were presented today at the 2017 scientific sessions of the American College of Cardiology (17–19 March, Washington,...

“Excellent early patency rates” for VEST device

Vascular Graft Solutions has announced interim results of VEST III, a post-market randomised controlled study, to demonstrate the clinical significance of the venous external...

New “smART” kit for radial access launched

​Centurion Medical Products has launched its “smART” kit for radial arterial catheterisation onto the market. According to a press release, the kit positively impacts...

Innovative Cardiovascular Solutions announces successful first use of its Emblok embolic...

  Innovative Cardiovascular Solutions has announced the successful first European clinical cases using its Emblok embolic protection system in patients undergoing transcatheter aortic valve implantation...

Five-fold increase in mortality in acute cardiac patients with delirium

A study published in European Heart Journal: Acute Cardiovascular Care indicates that delirium is associated with a five-fold increase in mortality in acute cardiac...

Early hospital discharge after TAVI less likely in women

A study, published in the Journal of Interventional Cardiology, indicates that females, bleeding, and blood transfusions—among others—are associated with lower odds for an early...

“Simple five-item risk score” could be used to predict bleeding risk...

Francesco Costa (Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland) and others report in The Lancet that the PRECISE-DAPT score—“a simple five-item risk...

Brian Brogie names as new vice president of manufacturing and facilities...

SynCardia, manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, has announced that Brian Brogie has...

Melody pulmonary heart valve receives FDA approval for valve-in-valve use

Following FDA approval, Medtronic’s Melody transcatheter pulmonary heart valve can now be used to treat patients whose surgical bioprosthetic pulmonary heart valves have failed....

New research indicates “harmless” painkillers are associated with an increased risk...

According to a study published in European Heart Journal–Cardiovascular Pharmacotherapy, painkillers that are traditionally considered harmless by the general public are associated with increased...

Study indicates that Impella heart pump reduces acute kidney injury during...

A new study published in Circulation Research finds that the use of haemodynamic support with Impella 2.5 heart pump during high-risk percutaneous coronary intervention...

American College of Cardiology update appropriate use criteria for performing coronary...

The American College of Cardiology (ACC), along with several partnering organisations, has released updated appropriate use criteria for performing coronary revascularisation in patients with...

ADVERT: SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System Drug Eluting stent technology with durable polymer has shown encouraging efficacy compared to bare metal stents, significantly reducing restenosis...

RenalGuard significantly reduces risk of contrast-induced acute kidney injury in high-risk...

A new meta-analysis, published in JACC: Cardiovascular Interventions, indicates that RenalGuard (RenalGuard Solutions) significantly reduces the risk of contrast-induced acute kidney injury in high-risk...

Cobra PzF stent approved for commercial use in the USA

The FDA has approved a nano-coated coronary stent system—CeloNova Biosciences’ Cobra PzF—for use in percutaneous coronary intervention (PCI), specifically to improve coronary luminal diameter....

Valve replacement may better than vavluloplasty for aortic stenosis patients with...

A new study published in Catheterization and Cardiovascular Interventions indicates that valve replacement, via surgery or transcatheter aortic valve implantation (TAVI), significantly increases survival...

Contemporary Issues in Complete Revascularisation

  This educational supplement is only for readers in countries outside Europe.  In this educational supplement, sponsored by Boston Scientific, Cardiovascular News explores both complete and...

“No-touch” CABG reduces postoperative stroke and short-term mortality

A network meta-analysis, published in the Journal of the American College of Cardiology, indicates that an off-pump coronary artery bypass grafting (CABG) technique that...

BTG’s EKOS control unit 4.0 receives FDA 510(K) clearance

FDA 510(k) clearance has been granted to BTG’s EKOS control unit 4.0. A press release reports that the system includes an ultrasonic device that...

FDA advisory panel recommend de novo approval of Sentinel cerebral protection...

In an open public hearing of the FDA’s circulatory system devices panel, according to a press release, nearly all panel members recommended the de...

Philips launch next-generation, image-guided therapy platform to enhance patient care and...

Philips has announced the global launch of Azurion—its next-generation image-guided therapy platform that integrates advanced interventional tools into one clinician platform. Combining advancements in...

Transradial PCI reduces costs

A new study published in JACC: Cardiovascular Interventions indicates that the transradial percutaneous coronary intervention (PCI) is associated with an average cost of US$13,389...

Locking mechanism problems prompt Boston Scientific to recall all ranges of...

According to Reuters, Boston Scientific is recalling all ranges of its transcatheter aortic valve implantation (TAVI) device Lotus. The news agency reports that the...

PCI does not confer mortality benefit for diabetic patients with chronic...

Ki Hong Choi (Division of Cardiology, Department of Medicine, Cardiac and Vascular Centre, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea)...

First patient enrolled in the US LEADERS FREE II trial of...

Biosensors has announced that the first patient has been enrolled in LEADERS FREE II—the BioFreedom pivotal study, which is being conducted under an investigational...

FDA approves Biotronik’s Pro-Kinetic Energy bare metal stent

Biotronik’s Pro-Kinetic Energy bare metal stent has received FDA approval, which is based on the results of the BIOHELIX-I clinical study. Therefore, the stent, which...

Physicians may be overlooking patients’ desire to avoid dual antiplatelet therapy...

A study, published in Catheterization and Cardiovascular Interventions, found that most patients undergoing coronary angiography believe that—following percutaneous coronary intervention (PCI)—avoiding dual antiplatelet therapy...

Cardiovascular News Issue 44 – February 2017 US edition

In Issue 44 (February 2017), we review why EXCEL and NOBLE had such different findings for left main PCI, the three-year outcomes of the ABSORB...

Cardiovascular News Issue 44 – February 2017

In Issue 44 (February 2017), we review why EXCEL and NOBLE had such different findings for left main PCI, the three-year outcomes of the ABSORB...

Rebecca Hahn

Rebecca Hahn (Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, USA) has been at the forefront of the developing field of interventional...

The implications of ABSORB II three-year results for the future of...

The idea of a fully bioresorbable scaffold is attractive as the need for mechanical support for the healing artery after percutaneous coronary intervention (PCI)...

Procedural complexity should be considered when deciding duration of dual antiplatelet...

Gennaro Giustino and others report in the Journal of American College of Cardiology that—alongside other established risk factors—procedural complexity “is an important parameter to...

Understanding and managing functional tricuspid regurgitation

Functional tricuspid regurgitation is increasingly recognised as an important clinical condition for which surgical repair is being applied.1 It primarily arises from left heart...

“Telestenting” is possible with robotic PCI

Ryan D Madder (Frederik Meijer Heart & Vascular Institute, Spectrum Health, Grand Rapids, USA) and others report in EuroIntervention that “telestenting”—ie. when the operator...

Meta-analysis indicates embolic protection does reduce stroke after TAVI

In a research letter published in the Journal of the American College of Cardiology, Gennaro Giustino (The Icahn School of Medicine, Mount Sinai Hospital,...

Performing PCI in comatose survivors of cardiac arrest

Because of a significant improvement in the prehospital treatment of patients with out-of-hospital cardiac arrest, an increasing number of resuscitated, comatose patients are being...

Transcatheter Mitral “valve-in-valve” replacement: The patient’s perspective

In this video, by Heart Valve Surgery, Paul Powers describes his life before and after undergoing transcatheter mitral "valve-in-valve" implantation. The procedure, he explains, was...

Terumo completes acquisition of vascular closure business and other assets of...

Terumo has announced that it has completed its acquisition of certain assets owned by Abbott and St Jude Medical. Terumo has acquired the Angio-Seal and...

Left atrial appendage thrombus may increase the risk of stroke after...

Sonny Palmer (St Vincent’s Hospital, Melbourne, Australia) and others report in JACC: Cardiovascular Interventions that left atrial appendage thrombus, as identified with computed tomography...

Homemade pelvic drape significantly reduces radiation exposure to the operator during...

The RADIATION (Radiation dose in percutaneous coronary procedures through transradial approach using dedicated radiation shields) study, published in EuroIntervention, indicates that using a lower...

TAVI company Direct Flow Medical closes after failing to secure funding

Direct Flow Medical, which markets a CE-marked transcatheter aortic valve implantation (TAVI) device, has closed after funding from a Chinese pharmaceutical company did not...

Combining MitraClip mitral valve repair with left atrial appendage occlusion is...

Shingo Kuwata (University Heart Center, Zurich, Switzerland) and others report in Eurointervention that atrial fibrillation is a “frequent comorbidity” in patients with mitral regurgitation...

JACC: Cardiovascular Imaging also to get a new editor-in-chief

Following the recent announcement from the American College of Cardiology (ACC) that David J Moliterno is to become the new editor-in-chief of JACC: Cardiovascular...

Boston Scientific may have resolved issue with Lotus Edge device

According a news report on Mass Device, Boston Scientific has “found a fix” for the problem with its next-generation transcatheter aortic valve implantation (TAVI)...

Enrolment completed for ACIST-FFR multicentre study

ACIST Medical Systems has announced that enrolment has been completed in its ACIST-FFR study—Assessment of catheter-based interrogation and standard techniques for fractional flow reserve...

David J Moliterno to become editor-in-chief of JACC: Cardiovascular Interventions

The American College of Cardiology (ACC) has named David J Moliterno (Jack M Gill Chair, Department of Internal Medicine, University of Kentucky, Lexington, USA)...

The management of leaflet thickening after TAVI remains controversial

Ryo Yanagisawa (Department of Cardiology, Keio University School of Medicine, Tokyo, Japan) and colleagues report in JACC: Cardiovascular Imaging that hypoattenuated leaflet thickening after...

Few cardiologists take steps to avoid radiation exposure during pregnancy despite...

The Women in Cardiology (WIC) section of the American College of Cardiology (ACC) report that 47% of female cardiologists have avoided being pregnant during...

CardiAMP heart failure trial initiated at two US centres

BioCardia has announced the initiation of its CardiAMP heart failure pivotal trial—a randomised, controlled, multicentre study of up to 260 patients evaluating CardiAMP cell...

MicroPort completes patient enrolment of VitaFlow pre-market clinical trial

MicroPort Medical has recently completed the patient enrolment of the pre-market clinical trial of its self-developed VitaFlow transcatheter aortic valve and delivery system (VitaFlow),...

First patient enrolled in Somahulation’s CABG European registry of DuraGraft

Somahlution has announced enrolment of the first patient in its DuraGraft coronary artery bypass grafting (CABG) European Registry. The registry will evaluate DuraGraft—a vascular...

Abbott completes acquisition of St Jude Medical

Abbott Vascular has completed its acquisition of St Jude Medical. This follows receipt of all regulatory clearances necessary for closing. A company press release states that the transaction establishes...

Transcatheter valve-in-ring implantation is feasible for reducing tricuspid regurgitation

A new study indicates that “transcatheter valve-in ring”—implanting a transcatheter valve in a surgically placed annuloplasty ring—may be a clinically effective approach for managing...

Perform PCI prior to TAVI in patients with both coronary artery...

Stephen Ramee (Ochsner Medical Center, New Orleans, USA) and others outline in a paper in JACC: Cardiovascular Interventions, the rationale for performing percutaneous coronary...

Patient with tricuspid regurgitation successfully treated with world’s first transcatheter tricuspid...

NaviGate Cardiac Structures has announced that a novel valved stent that can capture the enlarged annulus in patients with functional tricuspid regurgitation was successfully...

Santa is not checking his list about whether you’re naughty or...

A new study, published in The BMJ, indicates that for centuries, children have been lied to about Santa/St Nick/Father Christmas—he does not actually care...

Infection in the setting of STEMI

The association between infections and acute coronary syndromes has been the subject of interest for many years. Recent evidence demonstrates an increased risk of...

Revised European guidelines on cardiovascular disease prevention: What you need to...

The new European guidelines on cardiovascular disease prevention in clinical practice1 are an update of the version published in 2012.2 They represent an evidence-based...

Minimally invasive TAVI has “several potential benefits”

Recently, there has been a move towards transcatheter aortic valve implantation (TAVI) procedures that are more “minimally invasive”. In this interview, Jay Giri (Cardiovascular...

FDA pre-market approval for the Impella heart pump for high-risk PCI...

Abiomed has expanded its FDA pre-market approval for Impella heart pump use in high-risk percutaneous coronary interventions (PCI) to include its Impella CP heart...

Teleflex to acquire Vascular Solutions in US$1 billion deal

Teleflex is to acquire Vascular Solutions in a transaction valued at approximately US$1 billion. Under the terms of the agreement, Teleflex will acquire all...

Novel locking microcatheter could improve procedural success rates of chronic total...

  Simon Wilson (Royal Infirmary of Edinburgh, Edinburgh, UK) and others report in EuroIntervention that the use of a novel microcatheter with a guidewire locking...

CADILLAC risk score could be used to identify STEMI patients for...

Musa A Sharkawi (Department of Cardiovascular Medicine, Hartford Hospital, Hartford, USA) and others report in Catheterization and Cardiovascular Interventions that the CADILLAC risk score...

FDA grant Cardiac Dimensions investigational device exemption approval to conduct study

Cardiac Dimensions has received FDA approval for its investigational device exemption (IDE) CARILLON trial. The multicentre, blinded, randomised controlled trial is designed to evaluate...

Ran Kornowski

Ran Kornowski (Department of Cardiology, Cardiac Catheterization Laboratories, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel) talks to Cardiovascular News about his career...

Focusing on risk-adjusted mortality in public reporting produces misleading figures

In Catheterization and Cardiovascular Interventions, Lloyd Klein (Rush Medical College, Chicago, USA) and others outline the 2016 revised Society for Cardiac Angiography and Interventions...

Edward Lifesciences to acquire Valtech

Valtech Cardio has agreed to be acquired by Edwards Lifesciences. The acquisition will give Edwards access to Valtech’s Cardioband reconstruction system (Cardioband) for transcatheter...

Neovasc receives approval to launch European study of Tiara transcatheter mitral...

Neovasc has received both regulatory and ethics committee approval to initiate the Tiara transcatheter mitral valve replacement study (TIARA II) in Italy. The study...

RSNA 2016: Siemens Healthineers debuts innovative, robot-supported ARTIS pheno angiography system

At the 2016 meeting of the Radiological Society of North America (RSNA; 27 November–2 December, Chicago, USA), Siemens Healthineers has unveiled the robot-supported ARTIS pheno...

RSNA 2016: Toshiba Medical aims to transforms CT Imaging with the...

With the introduction of the AquilionTM ONE/GENESIS Edition, the new system from Toshiba Medical that builds upon a 10-year history of leadership in area...

OrbusNeich launch next generation of its Combo dual therapy stent

OrbusNeich launched its latest generation dual therapy stent, the Combo Plus. According to a press release, the Combo Plus has a unique anti-CD34 antibody...

CardioCel now approved for use in the UAE

Admedus has announced that, in collaboration with its regional partner Genpharm, it has received market approval for CardioCel in the United Arab Emirates (UAE)...

First Revivent transcatheter ventricular enhancement procedure for ischaemic cardiomyopathy performed in...

BioVentrix has announced the first clinical use in the Netherlands of its closed-chest Revivent transcatheter (TC) ventricular enhancement system. The less invasive ventricular enhancement...

AHA 2016: Mount Sinai cardiologists honoured

Valentin Fuster (director of Mount Sinai Heart and physician-in-chief of The Mount Sinai Hospital, New York, USA) and Jeffrey W Olin (professor of Cardiology and Director...

ADVERTORIAL: Enhanced deliverability means Trifecta™ valve is now easier to implant

The new St. Jude Medical™ Trifecta™ valve with Glide™ Technology (GT) features several enhancements that make the device easier to implant in patients with...

ADVERTORIAL: Know where you are with SyncVision technology

SyncVision (Philips Volcano) enables co-registration between angiogram and intravascular ultrasound (IVUS) images during percutaneous coronary intervention (PCI). Following recent CE mark and FDA clearance...

AHA 2016: Mortality rate with FFR-guided treatment of multivessel disease is...

The results of the FUTURE (Functional testing underlying revascularisation) trial indicate that the use of fractional flow reserve (FFR) to guide treatment—medical management, percutaneous...

AHA 2016: Heparin plus tirofiban is safe and effective for use...

A new study, by researchers from the Intermountain Medical Center Heart Institute (Salt Lake City, USA), indicates that there are no significant differences in...

HeartFlow FFRct approved for use in Japan

HeartFlow has announced the approval of its HeartFlow FFRCT analysis by the Japanese Ministry of Health, Labour and Welfare. A press release reports that...

AHA 2016: Low-dose rivaroxaban reduces clinically significant bleeding in PCI patients...

Two drug regimens involving low doses of rivaroxaban (Xarelto, Bayer)—one with a 15mg once daily dose of the drug and a P2Y12 inhibitor and...

AHA 2016: MOMENTUM 3 shows HeartMate 3 LVAD improves clinical outcomes...

The results of the MOMENTUM 3 US IDE clinical study, which were presented at a late-breaking clinical trial at the 2016 American Heart Association...

AHA 2016: Strong positive one-year data for Corvia Medical’s InterAtrial shunt...

Corvia Medical has announced one-year follow-up data from the REDUCE LAP-HF clinical study of its InterAtrial shunt device. The device is the world's first...

AHA 2016: Incomplete revascularisation after PCI increases risk of adverse events...

Ehrin J Armstrong (Section of Cardiology, Denver VA Medical Center and University of Colorado School of Medicine, Aurora, USA) and others report in JACC:...

AHA 2016: The Medicines Company and Alnylam Pharmaceuticals present positive results...

The Medicines Company and Alnylam Pharmaceuticals have announced positive results from the analysis of day 90 data for 497 patients, as well as analysis...

Trialign system successfully used to treat patient with tricuspid regurgitation because...

Mitralign has announced the successful compassionate use treatment of a patient suffering from tricuspid regurgitation due to a cardiac implantable electronic device lead, with...

AHA 2016: Two thirds of patients experience plaque regression with the...

Amgen has announced that adding its PCSK9 inhibitor evolocumab (Repatha) to optimised statin therapy results in statistically significant regression of atherosclerosis in patients with...

Cardiovascular Research Foundation to launch structural heart disease journal

The Cardiovascular Research Foundation (CRF) is to launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the...

Patient enrolment complete in study assessing use of dabigatran atrial fibrillation...

  Patient enrolment into the international Phase IIIb RE-DUAL PCI study is complete. The study is evaluating the safety and efficacy of dabigatran (Pradaxa, Boehringer...

Terumo to distribute STARSystem for radial access procedures in Europe

Terumo Europe has entered into a distribution agreement with New Zealand company Adept Medical to make the STARSystem available to clinicians working across Western...

Cardiovascular News Issue 43 – November 2016 US Edition

Highlights: Lower revascularisation rate means drug-eluting stents are still preferred despite no long-term survival benefit; Optical coherence tomography significantly improves functional outcomes after PCI;...

Cardiovascular News Issue 43 – November 2016

Highlights: Lower revascularisation rate means drug-eluting stents are still preferred despite no long-term survival benefit; Optical coherence tomography significantly improves functional outcomes after PCI;...

TCT 2016: Three-year data fail to show Absorb to be superior...

According to the three-year results of the ABSORB II trial, a bioresorbable vascular scaffold (Absorb, Abbott Vascular) does not provide superior vasomotor reactivity than...

TCT 2016: Different endpoints may have led to different outcomes for...

Two randomised controlled trials have produced what appears to be conflicting results for how left main percutaneous coronary intervention (PCI) compares with coronary artery...

TCT 2016: Patent foramen ovale closure is more effective than medical...

Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder (St Jude Medical) was...

Pacemaker after TAVI is associated with worse outcomes

A study in JACC: Cardiovascular Interventions indicates that patients who require a pacemaker after undergoing transcatheter aortic valve implantation (TAVI) often have worse outcomes...

Pfizer discontinues the global development of its investigational PCSK9 inhibitor

Pfizer is to discontinue the global clinical development program for bococizumab—its investigational PCSK9 inhibitor. According to a press release, the totality of clinical information...

510(K) clearance for Merit Medical’s SwiftNinja steerable microcatheter

Merit Medical has received 510(k) clearance for its SwiftNinja steerable microcatheter. The clearance covers peripheral and coronary applications. With the exception of Japan, Merit...

Fresenius Medical Care acquires Xenios AG

Xenios AG has become part of Fresenius Medical Care. A press release reports that Xenios is driving innovation in minimally invasive lung and heart...

Svelte Medical launches DIRECT III post-market registry study

Svelte Medical Systems has announced the start of enrolment in the DIRECT III post-market registry study. DIRECT III is an “all-comer” study in Europe...

NICE recommends dual antiplatelet therapy with ticagrelor and aspirin

The National Institute of Health and Care Excellence (NICE) has published a final appraisal determination that states dual antiplatelet therapy with ticagrelor 60mg (Brilique,...

TCT 2016: Positive data for transcatheter tricuspid repair with Trialign

Mitralign presented 30-day data from the SCOUT I study, which designed to evaluate the performance of its Trialign system for tricuspid repair, at the...

TCT 2016: Transfemoral TAVI improves quality of life in intermediate-risk patients

Data presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC, USA) indicate that intermediate-risk patients who undergo transcatheter aortic...

TCT 2016: Tiara TMVI device highlighted in presentations

Neovasc has announced today its notable presentations at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC, USA). On 31 October,...

TCT 2016: CoreValve Evolut R continues to be associated with good...

Medtronic has unveiled new clinical data that shows that patients treated with its self-expanding CoreValve  Evolut R transcatheter aortic valve implantation (TAVI) device continued...

NICE should develop heart valve guidelines says Heart Valve Voice

UK charity Heart Valve Voice has launched a report—Towards a Heart Healthy Future: a 2020 Vision for Heart Valve Disease’—that sets out recommendations to...

TCT 2016: “Excellent” rates of late lumen loss with Desolve bioresorbable...

Six-month clinical data for Elixir Medical’s bioresorbable scaffold (Desolve) were presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC,...

TCT 2016: Cardiovascular System initiates largest ever randomised trial of coronary...

At the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC, USA), Cardiovascular Systems debuted the design of its new ECLIPSE clinical...

Arterys receives 510(k) clearance for its cloud-based medical image visualization and...

Arterys has received 510(k) clearance from the FDA for its Arterys Software. This clearance allows the Arterys product to be used in clinical settings...

Charity believes NHS programme will leave hundreds of atrial fibrillation patients...

Arrhythmia Alliance, the UK-based heart rhythm charity, is calling on NHS England to reconsider a programme that it says will mean the “hundreds” of...

TCT 2016: High implant success rates with St Jude Medical’s Amulet...

A study presented at the last late-breaking trial session of the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington, DC, USA) indicates...

TCT 2016: Women and minorities have a significantly higher risk...

Data from the PLATINUM DIVERSITY trial, which was presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington DC, USA), indicates...

TCT 2016: SENTINEL trial fails to meet overall primary efficacy endpoint...

The SENTINEL trial, which was presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington , DC, USA) today, has not...

TCT 2016: Physicians discuss their positive experiences of using a metallic...

At a symposium at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington, DC, USA), physicians discussed their first experiences with a...

TCT 2016: First-in-human data shows Medtronic’s drug-filled stent to be non-inferior...

Results of the REVELUTION study, simultaneously presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington, DC, USA) and published in...

TCT 2016: Positive real-world data for CoreValve Evolut R presented

Today, Medtronic presented new positive data from two large registries aimed at evaluating 30-day clinical performance outcomes for its self-expanding, recapturable and repositionable CoreValve...

TCT 2016: FDA approve Amplatzer PFO occluder device ahead of first...

The FDA has approved St Jude Medical’s Amplatzer patent foramen ovale (PFO) occluder device for the prevention of stroke. Announced on 28 October, this...

TCT 2016: All comers study finds no differences between Orsiro, Synergy...

BIO-RESORT, presented at TCT today during a late-breaking trial session, has found no significant differences at one year between Medtronic's Resolute Integrity (a durable...

TCT 2016: ILUMEN III shows some advantages with OCT

ILUMEN III, the first late-breaking to be presented at the 2016 Transcatheter Cardiovascular Therapeutics meeting (29 October-2 November, Washington, DC, USA), has met its...

Tryton Medical enters into strategic agreement with Cardinal Health

Tryton Medical and Cardinal Health have announced that they have established a long-term strategic agreement for US distribution of the Tryton side-branch stent, pending...

Standardisation paper aims to enhance uniformity of FFR in clinical practice

Gabor Toth (University Heart Centre Graz, Graz, Austria), Bernard De Bruyne (Cardiovascular Research Center Aalst, OLV Clinic, Aalst, Belgien) and others outline, in the...

TCT 2016: Valtech to host symposium about mitral and tricuspid valve...

Valtech Cardio will present a symposium on mitral and tricuspid valve repair at the 2016 Transcatheter Cardiovascular Therapeutics conference (TCT) meeting (29 October–2 November,...

Promising initial results suggest smartphone app could aid detection of myocardial...

  According to a study by researchers from the University of Turku (Finland), a smartphone app could detect myocardial infarction. Requiring no extra equipment, the...

CorPath GRX robotic system receives FDA 510(k) clearance

Corindus Vascular Robotics has received 510(k) clearance from the FDA for its CorPath GRX, the second generation of its CorPath vascular robotic system. A...

TCT 2016: 30-day patient data from SCOUT I study to be...

Mitralign is to outline data for its Trialign tricuspid repair system at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC,...

FDA clear temporary pacing lead for use during TAVI and other...

BioTrace Medical has received FDA 510(k) clearance for its Tempo Lead, which a press release describes as an innovative temporary pacing lead that has...

St Jude Medical shareholders approve merger with Abbott

St Jude Medical has announced that, based on the preliminary voting results from St Jude Medical’s Annual Meeting of Shareholders held on 26 October, St...

FDA approval of 34mm CoreValve Evolut R means device is largest...

Medtronic has announced the FDA approval and US launch of the CoreValve Evolut R 34mm valve—the largest sized transcatheter aortic valve implantation (TAVI) system...

Miracor receives additional funding to expand clinical and commercial activities with...

Miracor Medical Systems has raised additional funding as part of its Series-C financing round. The recent closing was led by Peppermint VenturePartners (Peppermint), who...

TCT 2016: Philips showcases its latest suite of image guidance solutions...

The latest image guidance solutions of Philips will be featured at Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC).  The company, according...

Cardiac rehabilitation after acute myocardial infarction does not improve health status...

  A new study, published in JAMA Cardiology, indicates that health status outcomes in patients who undergo cardiac rehabilitation after an acute myocardial infarction are...

TAVI is “technically feasible” for managing aortic regurgitation in high-risk patients

Anna Franzone (Department of Cardiology, Swiss Cardiovascular Center, University Hospital, Bern, Switzerland) and others report in the JACC: Cardiovascular Interventions that transcatheter aortic valve implantation...

TCT 2016: CeloNova BioSciences announces key activities

CeloNova BioSciences has provided details of its activities at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October—2 November, Washington, DC, USA). A press...

TCT 2016: Boston Scientific announces scheduled presentations

Boston Scientific has announced key data that will be presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC, USA)....

Svelte Medical awarded CE mark for its Direct RX stent

Svelte Medical has received the CE mark for the Direct sirolimus-eluting coronary stent rapid-exchange (RX) system for treating coronary artery disease. The new stent...

TCT 2016: St Jude Medical to highlight latest cardiovascular portfolio

New data for St Jude Medical’s devices and technologies will be presented during late-breaking clinical trial presentations at the 2016 Transcatheter Cardiovascular Therapeutics (TCT)...

Adherence to medication more powerful predictor of adverse outcomes than type...

A study published in Circulation has not only found that patients who adhere to medical regimens after revascularisation have increased survival but also that...

TAVI at the end of life: Knowing when it is futile

Understanding how aggressively to treat patients in their last years of life is challenging for a number of reasons. Beyond the difficulty of predicting...

FDA approve clinical trial of a miniature heart assist device for...

The FDA has granted conditional approval to conduct an investigational device exemption (IDE) study of Jarvik Heart’s new miniature left ventricular assist device (LVAD)...

Health Canada grants licence to Medtronic for its CoreValve Evolut R...

Medtronic Canada has announced it has received a Health Canada licence for its recapturable, self-expanding CoreValve Evolut R System. A press release reports that...

Vascular Solutions receive FDA clearance for its Fluent inflation device

Vascular Solutions has received 510(k) clearance from the FDA for the Fluent inflation device for use during cardiovascular procedures to create, maintain, and monitor...

Study indicates that anger or emotional upset can trigger a myocardial...

Data from the INTERHEART study, published in Circulation, supports the theory that you can “give yourself a heart attack” by becoming angry or upset—finding...

TCT 2016: First live case featuring Desolve NXT scaffold to be...

Elixir Medical has announced that it will showcase the first live case demonstration by transmission in the USA of its Desolve NXT novolimus-eluting bioresorbable...

TCT 2016: Breakfast symposium to explore robotic therapy in interventional cardiology

Corindus Vascular Robotics is to host a breakfast symposium entitled “Robotic Therapy—current Applications & Future Vision” on 31 October at 7.00am at the 2016...

UK hospital to start largest study of its kind to evaluate...

Cardiologists at The James Cook University Hospital (Middlesbrough, UK), after receiving £1.6 million in NHS funding, are to initiate a trial—the UK Mini Mitral...

Wrist-worn heart rate monitors have variable accuracy

Robert Wang (The Heart and Vascular Institute, Cleveland Clinic, Cleveland, USA) and others report in JAMA Cardiology (in the form of a research letter)...

Positive top-line results for The Medicines Company’s PCSK9si

Data from the interim analysis of the ongoing ORION-1 study, which is evaluating The Medicines Company’s investigational first-in-class PCSK9 synthesis inhibitor, confirm the significant...

TCT 2016: Tryton Medical to hold clinical symposium on treatment of...

Tryton Medical has announced that it will be sponsoring a clinical symposium and exhibiting at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2...

St Jude Medical to form cyber security medical advisory board

St Jude Medical is to form a Cyber Security Medical Advisory Board (CSMAB) to advise the company as it, according to a press release,...

Experience matters when stenting the left main

According to a study published in JACC: Cardiovascular Interventions, patients undergoing left main coronary artery percutaneous coronary intervention (PCI) had better outcomes when the...

Suzette Jaskie appointed as vice president Global Medical Affairs at Corindus...

Corindus Vascular Robotics has announced that Suzette Jaskie has been appointed as vice president Global Medical Affairs at the company. A press release reports...

Twitter “may be useful” for researching how general public discuss cardiovascular...

Lauren Sinnenberg (@lsinnie Penn Medicine Social Media and Health Innovation Lab, University of Pennsylvania, Philadelphia, USA) and others report in JAMA Cardiology that Twitter may...

Mild-to-moderate chronic kidney disease no longer associated with worse outcomes after...

A new study indicates that patients with mild-to-moderate chronic kidney disease do not have worse outcomes after undergoing percutaneous coronary intervention (PCI) with a...

Prophylactic ipsilateral ulnar compression significantly reduces risk of radial artery occlusion

Samir B Pancholy (The Wright Center for Graduate Medical Education, The Commonwealth Medical College, Scranton, USA) and others report in JACC: Cardiovascular Interventions that...

BioStable Science & Engineering completes direct de novo application to FDA...

BioStable Science & Engineering has completed a direct de novo application to the FDA for Class II designation of its HAART 300 aortic annuloplasty...

Simplified TAVI device may benefit patients with rheumatic heart disease

At the South Africa Heart Association annual congress (8–11 September, Cape Town, South Africa), Jacques Scherman (Chris Barnard Division of Cardiothoracic Surgery, Groote Schuur...

FDA approves St Jude Medical’s PressureWire X guidewire

St Jude Medical has announced the FDA clearance and launch of its PressureWire X guidewire fractional flow reserve (FFR) measurement system. According to a...

Novel tricuspid therapy wins the 2016 EACTS Techno College Innovation Award

A novel device for treating tricuspid regurgitation has become the 2016 recipient of the European Association for Cardio-Thoracic Surgery (EACTS) Techno College Innovation Award....

Ian Meredith to become global chief medical officer of Boston Scientific

Ian Meredith, currently professor of Medicine and Cardiology for Monash University, Director of MonashHeart and Monash Health and as executive director of the Monash...

Heart transplant patient sees old heart in action

Kieran Sandwell, who was born with transposition of the great arteries, underwent a heart transplant in 2009. As a mark of gratitude for his new...

New vice president of US market development for CVRx

CVRx has appointed Tom Moore to the newly created, officer position of vice president, US Market Development. In this role, Moore will lead all field efforts...

An “opt-out” approach may encourage more patient participation in research

Shivan J Mehta (Department of Medicine, Perelman School of Medicine,  University of Pennsylvania, Philadelphia, USA) and others report in JAMA Cardiology that an “opt...

Data for The Medicines Company’s PCSK9si will be presented at AHA

Interim analysis results from ORION-1, which is evaluating The Medicines Company’s PCSK9si drug, will be presented during a late-breaking trial session at the 2016...

FDA deems two HeartWare HVAD recalls as “Class I”

Medtronic has reported that two previously communicated global voluntary recalls related to the HeartWare HVAD System have been categorised as Class 1 by the...

EACTS 2016: DuraGraft vascular graft treatment improves long-term outcomes after CABG

Somahlution announced the presentation of new data showing the its DuraGraft vascular graft treatment significantly improves long-term outcomes in coronary artery bypass grafting (CABG)...

Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent

The MAJESTIC trial set out to evaluate the performance of the Eluvia paclitaxel-eluting vascular stent system (Boston Scientific) in the treatment of femoropopliteal artery...

New brain lesions are found in 94% of patients following TAVI

A study published in the American Journal of Cardiology indicates that 94% of patients have evidence of new brain lesions after undergoing transcatheter aortic...

EACTS 2016: Positive one-year outcomes for Medtronic’s surgical aortic valve Avalus

Positive clinical data for Medtronic’s investigational Avalus pericardial aortic surgical valve were presented yesterday at the 2016 European Cardio-Thoracic Surgery (EACTS) annual meeting (1-5...

EACTS2016: World’s first heart valve that “enables cardiovascular restoration” successfully implanted...

Xeltis has announced that three pediatric patients have been successfully implanted with the world’s first heart valve enabling cardiovascular restoration. The three children were...

New “resilient” surgical aortic valve now available in Europe

Edwards Lifesciences has received the CE mark for its Inspiris Resilia aortic valve, which is the first in a new class of resilient heart...

NORSTENT shows bare metal stents have improved

The NORSTENT (Norwegian coronary stent trial) study, which was presented at the 2016 European Society of Cardiology congress (27–31 August, Rome, Italy) found no...

Heart team at Zurich University Hospital use Cardioband for tricuspid repair...

Francesco Maisano (University Hospital Zurich, Zurich, Switzerland) led a team of cardiac surgeons and cardiologists to perform percutaneous direct annuloplasty with the Cardioband system (Valtech)...

Japan approves Abiomed’s Impella 2.5 and Impella 5.0 heart pumps

Abiomed has announced that its heart pumps Impella 2.5 and Impella 5.0 have received Pharmaceuticals and Medical Devices Agency (PMDA) approval from the Japanese...

Xeltis established international clinical advisory board

Xeltis AG, a clinical-stage medical device company developing the first-ever heart valves designed to enable cardiovascular regeneration, announced today the formation of its international...

PCRLV 2016: MitraClip may be “safe and feasible” for treating tricuspid...

A first-in-man study indicates that percutaneous edge-to-edge repair with Abbott Vascular’s MitraClip system is a safe and feasible treatment for tricuspid regurgitation. According to...

PCRLV 2016: New approaches to TAVI are still being explored

Although much of the innovation in transcatheter solutions for structural heart disease is now focused on mitral and tricuspid approaches, novel devices for transcatheter...

Smartphones can help to streamline hospital transfer for myocardial infarction patients

A study published, as a research letter, in the Journal of the American College of Cardiology indicates that smartphone communication among medical teams at...

TriGuard cerebral protection associated with significant improvements in brain protection in...

Preliminary real-world findings, presented at PCR London Valves (18–20 September, London, UK), indicate that the use of the cerebral protection device (TriGuard, Keystone Heart)...

Positive top-line results from phase 3 GLAGOV imaging study of evolocumab

The Phase 3 GLAGOV (Global assessment of plaque regression with a PCSK9 antibody as measured by intravascular iltrasound) trial has met both its primary...

Claret Medical submits application for FDA approval of its cerebral protection...

Claret Medical has announced its filing of a marketing application with the FDA for clearance of the Sentinel cerebral protection system. According to a...

Transcatheter tricuspid valve repair performed at San Raffaele Hospital

4Tech’s transcatheter tricuspid valve repair device (TriCinch) has been used for the first time to treat patient with tricuspid regurgitation. The procedure was performed...

PCRLV 2016: Next-generation of Lotus TAVI receives CE mark

Coinciding with PCR London Valves (18-20 September, London, UK), Boston Scientific has announced it has received the CE mark for its Lotus Edge transcatheter...

Valtech to present first-in-human percutaneous tricuspid repair data at PCR London...

Valtech Cardio will present the first-in-human data for its Cardioband Tricuspid Repair (TR) system at PCR London Valves 2016 (18–20 September, London, UK). Updated...

First-in-human implants of Caisson Interventional’s percutaneous mitral valve device performed

Caisson Interventional has announced the first successful human implants of its fully percutaneous, transvascular mitral valve implant, which is designed as a functional replacement in...

The role of fractional flow reserve in managing STEMI patients with...

Recent studies have indicated that complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease is associated with better outcomes than...

ESC 2016: Bare metal stents inferior to drug-eluting stents for saphenous...

Data from a new study, BASKET-SAVAGE, indicate that patients who receive a drug-eluting stent when undergoing percutaneous coronary intervention (PCI) in a saphenous venous...

Terumo’s FineDuo microcatheter receives CE mark

FineDuo—a low profile, multifunctional, dual-lumen microcatheter—now has the CE mark. The device has been developed for use during percutaneous transluminal coronary angioplasty for guidewire...

CIRSE 2016: BTG launches βETA radiation safety programme

BTG has launched the βETA Radiation Safety Programme, a new initiative designed to reduce the risk of radiation exposure when performing selective internal radiation...

TCT 2016: Pivotal trial on cerebral protection device to be presented...

Data from the SENTINEL pivotal IDE trial will be presented during a late-breaking trial session at the  2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29...

TCT 2016: Late-breakers and first report investigations announced

The Cardiovascular Research Foundation (CRF) has announced the 11 late-breaking trials and 16 first report investigations that will be presented at the 2016 Transcatheter...

Redo TAVI procedures are safe and feasible

Marco Barbanti (Ferrarotto Hospital, University of Catania, Catania, Italy) and others report in Circulation: Cardiovascular Interventions that “redo” transcatheter aortic valve implantation (TAVI)—using TAVI...

“Keep it fast and simple” to avoid periprocedural stroke after TAVI

At PCR London Valves (18–20 September, London, UK), Holger Eggebrecht (Cardioangiological Center Bethanien and AGAPLESION Bethanien Hospital, Frankfurt, Germany) will give the talk “Preventing...

ESC 2016: Less unnecessary angiography with functional imaging

A study presented at the 2016 European Society of Cardiology (ESC) congress (27–31 August, Rome, Italy) indicates that functional imaging—using cardiac magnetic resonance (MR)...

ESC 2016: Adding N-acetylcysteine to glyceryl trinitrate reduces infarct size by...

A placebo-controlled, double-blind trial—NACIAM (N-acetylcysteine in acute myocardial infarction)—indicates that adding intravenous N-acetylcysteine to intravenous glyceryl trinitrate significantly reduced infarct size by approximately one...

ESC 2016: Rethink of ICD implantation in non-ischaemic heart failure may...

Implantable cardioverter-defibrillators (ICDs) do not improve overall long-term survival compared to medical treatment in patients with non-ischaemic systolic heart failure, according to results of...

No significant differences between Watchman and Amplatzer in first comparison

Results from the first study to compare outcomes of two left atrial appendage closure devices—Watchman (Boston Scientific) and Amplatzer (St Jude Medical)—indicate that there...

ESC 2016: First head-to-head comparisons of prasugrel and ticagrelor shows no...

The initial results of the first randomised controlled trial—PRAGUE 18—to directly compare prasugrel (Efient, Daiichi Sankyo) with ticagrelor (Brilinta, AstraZeneca) indicate there are no...

ESC 2016: Society welcomes the Pope to the congress

Pope Francis visited the 2016 European Society of Cardiology (ESC) congress (27-31 August, Rome, Italy) on the last day of the meeting. In this ESC video, the...

Philip Urban

Wanting to be like his father, Philip Urban (Cardiovascular Department, Hôpital de la Tour, Geneva, Switzerland) initially considered a career in banking. However, after...

Cardiovascular News Issue 42 – August 2016 US Edition

Highlights: Study indicates signal for valve degeneration in TAVI patients by eight years; Absorb now available in the USA following FDA approval; Profile of Philip...

Cardiovascular News Issue 42 – August 2016

Highlights: Study indicates signal for valve degeneration in TAVI patients by eight years; Absorb now available in the USA following FDA approval; Profile of Philip...

Pat Mackin appointed as a company director of Opsens

Opsens, which has an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease, has announced...

ESC 2016: “Costly and complex” platelet monitoring strategy does not appear...

Results from the ANTARCTIC study, which was simultaneously presented at the 2016 European Society of Cardiology congress (27–31 August, Rome, Italy) and published in The...

ESC 2016: Off-hours STEMI patients do not have worse outcomes

A new analysis of data from the CHAMPION PHOENIX (Cangrelor versus standard therapy to achieve optimal management of platelet inhibition) trial, published in the...

ESC 2016: Drug-eluting stents are still preferred despite no long-term survival...

The results of NORSTENT (Norwegian coronary stent trial) indicate that second-generation drug-eluting stents do not significantly reduce the long-term risk of all-cause mortality compared...

Rose Medical Center among first hospitals in Colorado to offer Watchman

Rose Medical Center has become one of the first hospitals in Colorado (USA) to offer patients with non-valvular atrial fibrillation percutaneous left atrial appendage closure...

Bolus version of Aggrastat is now approved in the USA

Medicure has received approval from the US Food and Drug Administration (FDA) for its new “bolus vial” product format for Aggrastat (tirofiban HCl). The...

More than half of women have sexual dysfunction in the year...

According to a study published in JAMA Cardiology, among those 18–55 years, more than half of women and just under half of men had...

ESC 2016: Optical coherence tomography significantly improves functional outcomes after PCI

Nicolas Meneveau
Nicolas Meneveau (Besancon, France) told delegates at the 2016 European Society of Cardiology (ESC) congress (27–31 August, Rome, Italy) that percutaneous coronary intervention (PCI)...

ESC 2016: Short-term DAPT is feasible with Nobori biodegradable polymer stent

The NIPPON (Nobori dual antiplatelet therapy as appropriate duration) study, presented in a hotline session at the ESC today, indicates that in patients undergoing...

Germany registry shows Zoll LifeVest wearable defibrillator to be safe and...

LifeVest
Zoll Medical has announced that results from the largest German registry of patients who were prescribed the company’s LifeVest wearable defibrillator reaffirm that the...

Automated external defibrillator accessibility: Barrier during cardiac arrest

  There is just a one in five chance that a potentially life-saving automated external defibrillator (AED) will be nearby when someone experiences cardiac arrest...

Advertorial: iFR Scout pullback assessment is “much more discriminatory” than FFR...

Physiological assessment with fractional flow reserve (FFR) is an established approach for determining the need for intervention in patients with stable coronary artery disease....

Philips to showcase “full suite” of cardiology solutions for diagnosis and...

A press release reports that Royal Philips will be showcasing its latest in advanced integrated cardiology solutions at the upcoming European Society of Cardiology...

Purchase of HeartWare by Medtronic completed

Medtronic has completed its acquisition of HeartWare International—a developer of less-invasive, miniaturised, mechanical circulatory support technologies for treating patients with advanced heart failure. HeartWare...

Zip surgical skin closure device associated with less pain for paediatric...

According to a study published in the Annals of Thoracic Surgery, the Zip surgical skin closure device (ZipLine Medical) is associated with significant improvements...

LAA closure for stroke prophylaxis in atrial fibrillation

This educational supplement is only for readers in countries outside France, Japan and the USA In this educational supplement, sponsored by Boston Scientific, Cardiovascular News...

Gender should not be a primary concern when deciding DAPT duration

A pre-specified analysis of PRODIGY (Prolonging dual antiplatelet treatment after grading stent-induced intimal hyperplasia study), published in JACC: Cardiovascular Interventions, indicates that gender is...

No advantage with beta-blockers post PCI for stable angina patients without...

Apurva Motivala (Division of Cardiology, Columbia University, New York, USA) and others report that patients who are prescribed beta-blockers after undergoing elective percutaneous coronary...

Siemens Healthineers’ unique imaging technologies: Smart solutions for challenging patients

In this supplement,* Cardiovascular News reviews how unique imaging technologies provide smart solutions for challenging patients. Contents include: 2 Increase in complex PCI is the “number one” trend in...

The ethics of testing new devices in developing countries

In this CTSNet video, filmed at the 2016 STS Annual Meeting (Phoenix, USA), Pieter Kappetein (Erasmus MC Thoraxcenter, Rotterdam, The Netherlands), Moritz Wyler von Ballmoos (Duke University...

Long-term study indicates no calcification with CardioCel after eight years

Long-term data from a Phase II extension study for the repair of congenital heart defects in paediatrics using CardioCel (Admedus) shows that all patients...

CMS recognises LAAO Registry as approved registry to meet national coverage...

An American College of Cardiology (ACC) press statement reports that the Centers for Medicare and Medicaid Services (CMS) has identified the LAAO Registry as...

FDA approval for Edwards Intuity Elite rapid deployment valve

Edwards Lifesciences has received FDA approval for its advanced Intuity Elite rapid deployment valve for surgical aortic valve replacement. A press release reports that...

Two major studies of Combo dual therapy stent complete enrolment

OrbusNeich has announced that two major clinical studies have now completed enrolment. The studies—HARMONEE (Harmonized assessment by randomised, multicentre study of OrbusNeich’s Combo stent)...

Corindus Vascular Robotics and Acist collaborate to improve PCI workflow for...

Corindus Vascular Robotics and Acist Medical Systems have come together to provide Fairview Southdale Hospital (Edina, USA) with three leading-edge technologies that are designed...

Drug-coated scoring balloon receives CE mark

Spectranetics has been granted the CE mark for its AngioSculptX Drug-coated percutaneous coronary transluminal angioplasty (PCTA) scoring balloon catheter.  A press release reports that...

Frequency of coronary perforation “might actually increase” given predictors include old...

Tim Kinnaird (Department of Cardiology, University Hospital of Wales, Cardiff, UK) and others report in Circulation: Coronary Interventions that older age and complex procedures,...

Cardiovascular researchers form consortium to address calls for data sharing

A group of cardiovascular researchers have formed a consortium—Academic Research Organization Consortium for Continuing Evaluation of Scientific Studies-Cardiovascular (ACCESS CV)—to develop strategies for sharing...

Mount Kilimanjaro climbing expedition to study effects of oxygen deprivation

Royal Philips, along with several other organisations, is to collaborate with the Mayo Clinic on an expedition to climb Mount Kilimanjaro to understand how the body reacts...

Boston Scientific issues urgent recall of Lotus systems manufactured prior to...

Boston Scientific has sent a letter to its customers notifying them that it is implementing a “voluntary Field Safety Corrective Action (FSCA)” for its...

Essential Medical to start US trial of X-Seal 6F vascular closure...

Essential Medical has received investigational device exemption (IDE) approval from the FDA to begin the US clinical trial for X-Seal, the company’s 6F vascular...

TMVI: What we know

Transcatheter mitral valve implantation (TMVI) is being explored as an approach to managing patients with mitral regurgitation who cannot undergo surgery. In this PCR,...

Absorb now available in the USA following FDA approval

Five years after receiving the CE mark, Abbott Vascular’s bioresorbable vascular scaffold (Absorb) has been granted FDA approval—making it the first fully dissolving scaffold...

Success of TAVI prompts surge in mitral valve technologies

Initially designed as a treatment for inoperable patients with aortic stenosis, because of encouraging results in high- and intermediate-risk patients as well as in...

Risk of device thrombosis may be significantly higher with Absorb than...

A network meta-analysis, published in JACC: Cardiovascular Interventions, indicates that three contemporary drug-eluting stents—Xience (a cobalt-chromium everolimus-eluting stent; Abbott Vascular), Promus (a platinum-chromium everolimus-eluting...

Metallic bioresorbable scaffold “can be considered as an alternative” to polymeric...

Michael Haude (Medical Clinic I, Städtische Kliniken Neuss, Neuss, Germany) and others report in the European Heart Journal that a second-generation, metallic bioresorbable scaffold...

TAVI with Sapien 3 may be better than surgery for intermediate-risk...

A ccording to Vinod H Thourani (Emory University School of Medicine, Atlanta, USA) and others, intermediate-risk patients undergoing transcatheter aortic valve implantation (TAVI) with the...

Moderate sedation during TAVI associated with significantly better outcomes

Jay Giri (Cardiovascular Medicine Division, Hospital of the University of Pennsylvania, Philadelphia, USA) reported at the annual meeting of the Society for Cardiac Angiography...

FDA gives Neovasc go-ahead to add 40mm valve size to its...

The FDA has given Neovasc approval for participating physicians to treat patients with the company’s 40mm Tiara valve in its TIARA-I early feasibility trial. The...

Age is a strong predictor of spontaneous myocardial infarction in medically...

Renato D Lopes (Division of Cardiology, Department of Medicine, Duke University School of Medicine, Duke Clinical Research, Durham, USA) and others report in the...

SCAI teams up with ASE to raise concerns about new imaging...

The Society for Cardiovascular Angiography and Interventions (SCAI) and the American Society of Echocardiography (ASE) have published a joint statement in Catheterisation and Cardiovascular...